【摘要】 维持性血液透析（maintenance hemodialysis, MHD）是终末期肾脏病（end-stage renal disease, ESRD）患者最常见的肾脏替代治疗，同时也是维持生命的重要措施。在过去的20年中，血液透析妊娠的发生率有所增加，预后显著改善，胎儿存活率现已接近80%。为更好地了解透析患者怀孕的特点、剂量调整和母胎风险，本文汇报1例维持血液透析9年患者成功分娩的病例。更多还原

【Abstract】 Maintenance hemodialysis(MHD) is the most common renal replacement therapy for patients with endstage renal disease(ESRD) and also an important measure to sustain life. Over the past 20 years, the incidence of hemodialysis pregnancies has increased, the prognosis has improved significantly, and the fetal survival rate is now close to 80%. To better understand the characteristics, dose adjustment and maternal-fetal risks of pregnancy in dialysis patients, this article reports a case of successful delivery in a patient on maintenance hemodialysis for 9 years.更多还原